Indeed, it was recently demonstrated by our research group that the use of HDAC inhibitors led to a reduction in glioma cell proliferation and the induction of apoptosis both in adherent and glioma stem-like cells, as well as those sensitized with RT [21]. This evidence concerns the gene HDAC9 and glioma.